Biovie

BIVINasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$13.775 M

$1.63 +0.00%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$17.5M

Loss-making

Shares outstanding

7,542,638

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Biovie lists more than one class of stock. Company figures above cover all classes combined.

BIVIW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#412Citius PharmaceuticalsCTXR$16.4M
#413Lisata TherapeuticsLSTA$16.0M
#414BiovieBIVI$13.8M
#415VyomeHIND$13.7M
#416NeuroSense TherapeuticsNRSN$13.6M

What if Biovie were worth as much as…

Open the what-if tool →

Gold $30.2T

$3,577,499

Per share 2,194,784× higher

Bitcoin $1.74T

$206,085.03

Per share 126,433× higher

Nvidia $5.52T

$652,664.83

Per share 400,408× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Biovie are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.